Logo image of MCRI

MONARCH CASINO & RESORT INC (MCRI) Stock Fundamental Analysis

NASDAQ:MCRI - Nasdaq - US6090271072 - Common Stock - Currency: USD

89.805  +0.37 (+0.41%)

Fundamental Rating

7

Overall MCRI gets a fundamental rating of 7 out of 10. We evaluated MCRI against 133 industry peers in the Hotels, Restaurants & Leisure industry. Both the health and profitability get an excellent rating, making MCRI a very profitable company, without any liquidiy or solvency issues. MCRI is not valued too expensively and it also shows a decent growth rate. With these ratings, MCRI could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

MCRI had positive earnings in the past year.
In the past year MCRI had a positive cash flow from operations.
Each year in the past 5 years MCRI has been profitable.
In the past 5 years MCRI always reported a positive cash flow from operatings.
MCRI Yearly Net Income VS EBIT VS OCF VS FCFMCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.44%, MCRI belongs to the top of the industry, outperforming 87.22% of the companies in the same industry.
MCRI's Return On Equity of 13.88% is fine compared to the rest of the industry. MCRI outperforms 74.44% of its industry peers.
MCRI has a Return On Invested Capital of 16.85%. This is amongst the best in the industry. MCRI outperforms 87.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MCRI is above the industry average of 13.81%.
The last Return On Invested Capital (16.85%) for MCRI is above the 3 year average (16.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.44%
ROE 13.88%
ROIC 16.85%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
MCRI Yearly ROA, ROE, ROICMCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 14.14%, MCRI belongs to the top of the industry, outperforming 87.97% of the companies in the same industry.
In the last couple of years the Profit Margin of MCRI has grown nicely.
Looking at the Operating Margin, with a value of 23.31%, MCRI belongs to the top of the industry, outperforming 86.47% of the companies in the same industry.
In the last couple of years the Operating Margin of MCRI has grown nicely.
MCRI has a better Gross Margin (53.84%) than 62.41% of its industry peers.
MCRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.31%
PM (TTM) 14.14%
GM 53.84%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
MCRI Yearly Profit, Operating, Gross MarginsMCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MCRI is creating value.
Compared to 1 year ago, MCRI has less shares outstanding
The number of shares outstanding for MCRI has been increased compared to 5 years ago.
There is no outstanding debt for MCRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MCRI Yearly Shares OutstandingMCRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCRI Yearly Total Debt VS Total AssetsMCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 7.89 indicates that MCRI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.89, MCRI belongs to the top of the industry, outperforming 92.48% of the companies in the same industry.
MCRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.89
ROIC/WACC1.88
WACC8.96%
MCRI Yearly LT Debt VS Equity VS FCFMCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MCRI has a Current Ratio of 0.69. This is a bad value and indicates that MCRI is not financially healthy enough and could expect problems in meeting its short term obligations.
MCRI has a Current ratio of 0.69. This is in the lower half of the industry: MCRI underperforms 62.41% of its industry peers.
A Quick Ratio of 0.64 indicates that MCRI may have some problems paying its short term obligations.
MCRI's Quick ratio of 0.64 is on the low side compared to the rest of the industry. MCRI is outperformed by 61.65% of its industry peers.
The current and quick ratio evaluation for MCRI is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.64
MCRI Yearly Current Assets VS Current LiabilitesMCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.86% over the past year.
The Earnings Per Share has been growing by 23.69% on average over the past years. This is a very strong growth
Looking at the last year, MCRI shows a small growth in Revenue. The Revenue has grown by 3.83% in the last year.
MCRI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.95% yearly.
EPS 1Y (TTM)19.86%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%12.9%
Revenue 1Y (TTM)3.83%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%3.07%

3.2 Future

The Earnings Per Share is expected to grow by 1.86% on average over the next years.
Based on estimates for the next years, MCRI will show a small growth in Revenue. The Revenue will grow by 2.19% on average per year.
EPS Next Y4.07%
EPS Next 2Y3.49%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue Next Year3.37%
Revenue Next 2Y2.89%
Revenue Next 3Y2.19%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MCRI Yearly Revenue VS EstimatesMCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
MCRI Yearly EPS VS EstimatesMCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.71, the valuation of MCRI can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of MCRI indicates a somewhat cheap valuation: MCRI is cheaper than 78.95% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MCRI to the average of the S&P500 Index (27.28), we can say MCRI is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.94, MCRI is valued correctly.
Based on the Price/Forward Earnings ratio, MCRI is valued a bit cheaper than 69.17% of the companies in the same industry.
MCRI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.71
Fwd PE 16.94
MCRI Price Earnings VS Forward Price EarningsMCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MCRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 75.19% of the companies in the same industry.
78.95% of the companies in the same industry are more expensive than MCRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.58
EV/EBITDA 9.03
MCRI Per share dataMCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MCRI does not grow enough to justify the current Price/Earnings ratio.
MCRI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.35
PEG (5Y)0.75
EPS Next 2Y3.49%
EPS Next 3Y1.86%

3

5. Dividend

5.1 Amount

MCRI has a Yearly Dividend Yield of 1.39%.
MCRI's Dividend Yield is a higher than the industry average which is at 3.71.
Compared to an average S&P500 Dividend Yield of 2.42, MCRI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

MCRI has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MCRI Yearly Dividends per shareMCRI Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

MCRI pays out 29.76% of its income as dividend. This is a sustainable payout ratio.
DP29.76%
EPS Next 2Y3.49%
EPS Next 3Y1.86%
MCRI Yearly Income VS Free CF VS DividendMCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
MCRI Dividend Payout.MCRI Dividend Payout, showing the Payout Ratio.MCRI Dividend Payout.PayoutRetained Earnings

MONARCH CASINO & RESORT INC

NASDAQ:MCRI (7/3/2025, 11:12:05 AM)

89.805

+0.37 (+0.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners67.19%
Inst Owner Change1.22%
Ins Owners22.86%
Ins Owner Change-0.05%
Market Cap1.66B
Analysts50
Price Target89.76 (-0.05%)
Short Float %1.62%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly Dividend1.19
Dividend Growth(5Y)N/A
DP29.76%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.45%
Min EPS beat(2)4.02%
Max EPS beat(2)20.88%
EPS beat(4)4
Avg EPS beat(4)8.87%
Min EPS beat(4)4.02%
Max EPS beat(4)20.88%
EPS beat(8)4
Avg EPS beat(8)-0.24%
EPS beat(12)5
Avg EPS beat(12)-1.13%
EPS beat(16)8
Avg EPS beat(16)0.7%
Revenue beat(2)2
Avg Revenue beat(2)1.21%
Min Revenue beat(2)0.23%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)6
Avg Revenue beat(12)0.35%
Revenue beat(16)9
Avg Revenue beat(16)2.36%
PT rev (1m)0%
PT rev (3m)-4.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.02%
EPS NY rev (1m)0%
EPS NY rev (3m)1.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 17.71
Fwd PE 16.94
P/S 3.15
P/FCF 18.58
P/OCF 11.94
P/B 3.1
P/tB 3.26
EV/EBITDA 9.03
EPS(TTM)5.07
EY5.65%
EPS(NY)5.3
Fwd EY5.9%
FCF(TTM)4.83
FCFY5.38%
OCF(TTM)7.52
OCFY8.37%
SpS28.47
BVpS29
TBVpS27.55
PEG (NY)4.35
PEG (5Y)0.75
Profitability
Industry RankSector Rank
ROA 10.44%
ROE 13.88%
ROCE 21.79%
ROIC 16.85%
ROICexc 19.45%
ROICexgc 20.58%
OM 23.31%
PM (TTM) 14.14%
GM 53.84%
FCFM 16.97%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
ROICexc(3y)17.94%
ROICexc(5y)14.16%
ROICexgc(3y)18.89%
ROICexgc(5y)14.91%
ROCE(3y)21.22%
ROCE(5y)16.86%
ROICexcg growth 3Y10.75%
ROICexcg growth 5Y23.79%
ROICexc growth 3Y10.64%
ROICexc growth 5Y23.89%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 95.28%
Cap/Sales 9.44%
Interest Coverage 126.53
Cash Conversion 79.5%
Profit Quality 120.04%
Current Ratio 0.69
Quick Ratio 0.64
Altman-Z 7.89
F-Score6
WACC8.96%
ROIC/WACC1.88
Cap/Depr(3y)95.66%
Cap/Depr(5y)184.37%
Cap/Sales(3y)9.04%
Cap/Sales(5y)17.42%
Profit Quality(3y)131.09%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.86%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%12.9%
EPS Next Y4.07%
EPS Next 2Y3.49%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue 1Y (TTM)3.83%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%3.07%
Revenue Next Year3.37%
Revenue Next 2Y2.89%
Revenue Next 3Y2.19%
Revenue Next 5YN/A
EBIT growth 1Y5.07%
EBIT growth 3Y8.5%
EBIT growth 5Y24.7%
EBIT Next Year59.89%
EBIT Next 3Y18.02%
EBIT Next 5YN/A
FCF growth 1Y-29.39%
FCF growth 3Y4.73%
FCF growth 5YN/A
OCF growth 1Y-16.28%
OCF growth 3Y3.18%
OCF growth 5Y17.36%